▲TegoScience=Announced that no adverse reactions occurred in the Phase 1/2 clinical trial of TPX-115, a cell therapy for partial rotator cuff tear, indicating excellent safety and tolerability.
▲JNTC=Announced the extension of payment guarantee for 35.8 billion KRW borrowed by its overseas subsidiary from Woori Bank Singapore Branch.
▲SGC E-Tech Construction=Announced a change to a co-CEO system with An Chan-gyu and Lee Woo-sung. Also announced an increase in short-term borrowings from non-financial institutions amounting to 80 billion KRW to secure liquidity.
▲SaevitChem=Announced the acquisition of land near Gimcheon-si, Gyeongsangbuk-do for approximately 3.2 billion KRW to enter a new business.
▲Infomark=Announced the decision to conduct a general public paid-in capital increase worth 1 billion KRW to raise operating funds.
▲New Power Plasma=Announced the decision to acquire treasury shares worth 5 billion KRW to stabilize stock price and enhance shareholder value.
▲Snet=Announced the decision to issue convertible bonds worth 5 billion KRW to raise operating funds.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
